7 Mid-Cap Stocks With the Highest Gains in April
In this piece, we discuss the 7 Mid-Cap Stocks With the Highest Gains in April.
Posts Tagged ‘NASDAQ:SLNO’
10 Stocks With Unexpected Gains
Ten stocks kicked off the trading week with significant gains, mirroring Wall Street's broader optimism, as investors cheered strong US jobs data while waiting on the sidelines...
Soleno Therapeutics’ (SLNO) Investor Sentiment Subdued Amid Growth Concerns
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter 2025 investor letter.
7 Best Small-Cap Healthcare Stocks to Buy According to Hedge Funds
In this article, we will look at the best small-cap healthcare stocks to buy according to hedge funds.
H.C. Wainwright Lowers PT on Soleno (SLNO), Keeps a Buy Rating
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the Best Small-Cap Growth Stocks to Buy According to Hedge Funds. On March 4, H.C.
12 Best Small-Cap Growth Stocks to Buy According to Hedge Funds
On February 5, Simeon Hyman, Global Investment Strategist at ProShares, appeared on a Schwab Network interview to discuss how investors can capitalize on market rotation.
Soleno Therapeutics, Inc. (SLNO) Revenue Tops Expectations With $91.7M in Q4 Results, TD Cowen Maintains Buy
Soleno Therapeutics, Inc. (NASDAQ:SLNO) ranks among the most shorted stocks to buy according to analysts. On February 25, Soleno Therapeutics, Inc.
Wells Fargo Cuts PT on Soleno Therapeutics (SLNO) to $110 From $114 – Here’s Why
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the best cheap biotech stocks to buy now. Wells Fargo cut the price target on Soleno Therapeutics, Inc.
12 Cheap Biotech Stocks to Buy Now
In this article, we will look at the 12 Cheap Biotech Stocks to Buy Now.
11 Most Shorted Stocks to Buy According to Analysts
In this article, we will take a look at the 11 Most Shorted Stocks to Buy According to Analysts.
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Q4 2025 Earnings Call Transcript
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Q4 2025 Earnings Call Transcript February 26, 2026 Operator: Good afternoon, and thank you for standing by.
Soleno Therapeutics (SLNO) Sparks Confidence Amid Topline Outperformance
Soleno Therapeutics (NASDAQ:SLNO) is one of the 17 biotechnology stocks with more than 50% upside.
17 Biotechnology Stocks with More Than 50% Upside
2025 was a year characterized by both challenges and opportunities for the biotechnology sector.
10 Cheap Stocks with Huge Upside Potential
We’re only one month into 2026, and the progress of global economies has been anything but normal.
Is Soleno Therapeutics, Inc. (NASDAQ:SLNO) The Best Under $50 Stock to Buy Now?
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is among the stocks under $50 to buy now. On January 20, TheFly reported that H.C.
12 Stocks Under $50 to Buy Now
In this article, we will take a look at the stocks under $50 to buy now.
Soleno Therapeutics Inc. (SLNO): Analysts See Major Upside
Soleno Therapeutics Inc. (NASDAQ:SLNO) is one of the best cheap stocks that will skyrocket.
10 Best Cheap Stocks That Will Skyrocket
In this article, we will take a look at the 10 Best Cheap Stocks That Will Skyrocket.
12 Stocks that Will Bounce Back According to Wall Street Analysts
On January 5, Reuters reported that many analysts believe global investors will actively look for opportunities in undervalued areas of the financial markets in 2026.
Do You Believe in the Growth Prospects of Soleno Therapeutics (SLNO)?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” third-quarter 2025 investor letter.
Is Soleno Therapeutics, Inc. (SLNO) The Cheap Healthcare Stock To Buy Heading Into 2026?
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Soleno Therapeutics, Inc.
12 Cheap Healthcare Stocks to Buy Heading into 2026
In this article, we will take a look at the cheap healthcare stocks to buy heading into 2026.
Analyst Dismisses ViCAT XR Safety Fears, Expects Strong Growth Despite Recent Stock Weakness
Soleno Therapeutics Inc. (NASDAQ:SLNO) is one of the best upside stocks to buy now.
12 Best Upside Stocks to Buy Now
On November 14, Alli McCartney, UBS Private Wealth Management managing director, joined 'Squawk Box' on CNBC to discuss the latest market trends and what to make of the recent...
Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns
Soleno Therapeutics, Inc. (NASDAQ:SLNO) ranks among the most oversold biotech stocks to invest in. Soleno Therapeutics, Inc.
9 Oversold Biotech Stocks to Invest In
In this article, we will take a look at 9 Oversold Biotech Stocks to Invest In.
Wolfe Research Initiates Soleno Therapeutics (SLNO) Coverage with Outperform Rating, $75 PT, Dismisses Patient Slowdown Concerns
Soleno Therapeutics Inc. (NASDAQ:SLNO) is one of the cheap US stocks to buy according to analysts.
10 Cheap US Stocks to Buy According to Analysts
On November 13, Carol Schleif, BMO private wealth chief market strategist, joined 'Squawk Box' on CNBC to discuss the latest market trends, state of the economy, and takeaways...
Soleno Therapeutics (SLNO) Ends 26% Lower After Q3 Earnings
We recently published 10 Stocks Left Behind Amid Wall Street Cheer. Soleno Therapeutics Inc. (NASDAQ:SLNO) is one of the worst-performing stocks on Wednesday.
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Q3 2025 Earnings Call Transcript
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Q3 2025 Earnings Call Transcript November 5, 2025 Operator: Good afternoon, and thank you for standing by.
Soleno Therapeutics, Inc. (SLNO): A Bull Case Theory
We came across a bullish thesis on Soleno Therapeutics, Inc. on X.com by seedy19tron. In this article, we will summarize the bulls’ thesis on SLNO.
Goldman Sachs Initiates Coverage of Soleno Therapeutics (SLNO) With a Buy Rating
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the best healthcare stocks with the highest upside. Goldman Sachs initiated coverage of Soleno Therapeutics, Inc.
9 Best Healthcare Stocks with the Highest Upside
In this article, we will look at the 10 Best Healthcare Stocks with the Highest Upside. On October 9, Dr.
Piper Sandler Maintains a Buy Rating on Soleno Therapeutics (SLNO), Sets a $145 PT
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the best biotech stocks with high potential.
14 Biotech Stocks with High Potential
In this article, we will look at the top 14 Biotech Stocks with High Potential.
Wells Fargo Reiterates a Buy Rating on Soleno Therapeutics (SLNO), Sets a PT of $123
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the best strong buy stocks to invest in according to Wall Street.
12 Best Strong Buy Stocks to Invest in According to Wall Street
In this article, we will look at the 12 Best Strong Buy Stocks to Invest in According to Wall Street.
Soleno Therapeutics (SLNO) Jumps 13.46% as Competitor Fails Prader-Willi Treatment Trial
We recently published 10 Stocks Crushing Wall Street, AI Stocks Dominate. Soleno Therapeutics Inc. (NASDAQ:SLNO) is one of the top performers on Tuesday.
Soleno Therapeutics, Inc. (SLNO) Targets EMA Approval as U.S. Launch of VYKAT XR Expands
In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Soleno Therapeutics, Inc. is one of them. Soleno Therapeutics, Inc.
13 Most Oversold Healthcare Stocks So Far in 2025
In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025.
Soleno Therapeutics (SLNO) Falls Hard on Patient Death
We recently published 10 Stocks Melt Down in Hours. Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the worst performers on Wednesday.
11 Best Stocks to Buy for the Next 3 Months According to Hedge Funds
In this article, we will look at the 11 Best Stocks to Buy for the Next 3 Months According to Hedge Funds.
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Q2 2025 Earnings Call Transcript
Soleno Therapeutics, Inc.
Soleno Therapeutics’ Vykat XR Exceeds Sales Expectations
Soleno Therapeutics Inc. (NASDAQ:SLNO) is one of the best performing mid cap stocks so far in 2025.
11 Best Performing Mid Cap Stocks So Far In 2025
On July 1, Alan McKnight, the CIO at Regions Wealth Management, appeared on CNBC to explain how his biggest worry is currently centered around uncertainty, which he believes leads...
TD Cowen Starts Coverage Soleno Therapeutics (SLNO) Stock, Gives Buy
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the 10 Unstoppable Stocks to Buy According to Hedge Funds.
10 Unstoppable Stocks to Buy According to Hedge Funds
In this article, we will discuss the 10 Unstoppable Stocks to Buy According to Hedge Funds.
FDA Approval for its Drug Lifted Soleno Therapeutics (SLNO) Shares by 60%
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” first-quarter 2025 investor letter.
Piper Sandler Reaffirms Overweight Rating on Soleno (SLNO) Driven by Strong VYKAT XR Prospects
Soleno Therapeutics Inc. (NASDAQ:SLNO) is one of the 10 biotech stocks screaming a buy now.
10 Biotech Stocks Screaming a Buy
In this article, we will look at the 10 Biotech Stocks Screaming a Buy. The biotech sector has underperformed the overall market.
Hedge Fund Resource Center
